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Introduction
Parkinson’s disease is a common aging-related neurodegenera-
tive disorder, which is characterized by the selective loss of   
dopamine neurons in the substantia nigra pars compacta (SNpc) 
of the brain. Despite intense research, mechanisms underlying 
selective dopamine neuron death are not well defined. Inhibition 
of mitochondrial complex I has long been one of the leading 
theories (Abou-Sleiman et al., 2006). The observation that drug 
abusers accidentally exposed to 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) developed Parkinsonism provided 
the  first  evidence  for  this  hypothesis  because  1-methyl-4-
phenylpyridinium (MPP
+), the toxic metabolite of MPTP, is a 
mitochondrial complex I inhibitor (Langston et al., 1983; Dauer 
and Przedborski, 2003). Furthermore, complex I activity is de-
creased in the substantia nigra, skeletal muscle, and platelets of 
patients with Parkinson’s disease (Mizuno et al., 1989; Parker   
et al., 1989; Schapira et al., 1989). A recent study suggests that 
some of the subunits of complex I in human Parkinson’s disease 
brains are oxidatively damaged, resulting in the misassembling 
and functional impairment of complex I (Keeney et al., 2006).
Chronic treatment of rats and mice with rotenone, a well-
established complex I inhibitor, induces many key features of 
Parkinson’s disease (Betarbet et al., 2000; Sherer et al., 2003b; 
Inden et al., 2007; Pan-Montojo et al., 2010). These findings 
provide further support for the mitochondrial complex I inhibi-
tion hypothesis. Ectopic expression of the Ndi1 gene, a rotenone- 
and MPP
+-insensitive single-subunit NADH dehydrogenase from 
Saccharomyces cerevisiae, protects dopamine neurons against 
MPTP and rotenone toxicities in vitro and in vivo, leading to the 
conclusion that complex I inhibition is obligatory for dopamine 
neuron death in the rotenone and MPTP models of Parkinson’s 
disease (Sherer et al., 2003a, 2007; Seo et al., 2006; Richardson 
et al., 2007; Marella et al., 2008).
To examine the concept that complex I inhibition under-
lies dopamine neuron degeneration, we studied a mouse strain 
lacking a functional Ndufs4 gene that encodes one of the 46 
M
itochondrial complex I dysfunction is regarded 
as underlying dopamine neuron death in Par-
kinson’s disease models. However, inactivation 
of the Ndufs4 gene, which compromises complex I activ-
ity, does not affect the survival of dopamine neurons in 
culture  or  in  the  substantia  nigra  pars  compacta  of   
5-wk-old mice. Treatment with piericidin A, a complex I in-
hibitor, does not induce selective dopamine neuron death 
in either Ndufs4
+/+ or Ndufs4
/ mesencephalic cultures. 
In contrast, rotenone, another complex I inhibitor, causes 
selective  toxicity  to  dopamine  neurons,  and  Ndufs4  
inactivation potentiates this toxicity. We identify microtubule 
depolymerization and the accumulation of cytosolic dopa-
mine and reactive oxygen species as alternative mech-
anisms  underlying  rotenone-induced  dopamine  neuron 
death. Enhanced rotenone toxicity to dopamine neurons 
from Ndufs4 knockout mice may involve enhanced dopa-
mine  synthesis  caused  by  the  accumulation  of  nicotin-
amide adenine dinucleotide reduced. Our results suggest 
that the combination of disrupting microtubule dynamics 
and inhibiting complex I, either by mutations or exposure 
to toxicants, may be a risk factor for Parkinson’s disease.
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cells (IC50 = 20 or 10 nM for rotenone or piericidin A, respectively; 
Fig. 1, A and B). We used antibodies against tyrosine hydroxylase 
(TH), the rate-limiting enzyme in dopamine biosynthesis, as a 
marker for dopamine neurons. Although 5 nM rotenone had 
very little effect on complex I activity, it selectively killed 50% 
of the TH
+ dopamine neurons (Fig. 1 C). In contrast, 20 nM 
piericidin A, which inhibited 65–70% of complex I activity, did 
not induce selective dopamine neuron death (Fig. 1 D).
We next quantified the number of TH
+ dopamine neurons 
in the SNpc of 5-wk-old Ndufs4
+/+ and Ndufs4
/ mice by ste-
reological analysis. Although Ndufs4
/ mice die at postnatal 
week 7, they appear healthy until 5 wk of age (Kruse et al., 
2008). The TH-staining  pattern  and  cell  distribution  were 
comparable in both genotypes (Fig. 2 A). There was no differ-
ence in the total number of TH
+ dopamine neurons in the 
SNpc (Fig. 2 B). Similar results were obtained with 6–7-wk-
old mice (Fig. S1). The number of NeuN
+ (neuronal nuclei)   
total neurons in the SNpc was also similar in both Ndufs4
+/+ and 
Ndufs4
/ mice (unpublished data).
One might argue that the Ndufs4 deletion in Ndufs4
/ 
mice  causes  developmental  compensation  by  other  genes  or 
other developmental defects that minimize the effect of complex I 
inhibition on dopamine neuron death. An in vitro gene knockout 
system was used to exclude this possibility. Primary mesence-
phalic neurons were cultured from wild-type or Ndufs4
lox/lox  
embryos  and  infected  with  an  adeno-associated  virus  (AAV)   
expressing Cre-GFP. Western analysis confirmed that AAV-Cre 
indeed knocked down Ndufs4 protein expression in Ndufs4
lox/lox 
subunits comprising mitochondrial complex I and is required 
for complete assembly and function of complex I (van den 
Heuvel et al., 1998; Budde et al., 2000; Petruzzella and Papa, 
2002; Scacco et al., 2003; Vogel et al., 2007). We confirmed that 
deletion of the Ndufs4 gene abolished complex I activity in mid-
brain mesencephalic neurons cultured from embryonic day (E) 
14 mice (Choi et al., 2008). Surprisingly, dopamine neurons in 
Ndufs4
/ cultures appeared normal and survived as well as 
neurons from wild-type mice (Choi et al., 2008). The absence of 
complex I activity did not protect dopamine neurons against 
MPP
+ or rotenone toxicity as would be expected if these com-
pounds act by inhibiting complex I, and Ndufs4
/ dopamine 
neurons were even more sensitive than Ndufs4
+/+ neurons to   
rotenone toxicity (Choi et al., 2008). These data question the 
long-held complex I inhibition hypothesis and suggest that there 
is a complex I–independent mechanism that renders dopamine 
neurons more susceptible than other neurons to rotenone and 
MPP
+. In this study, we provide further evidence to support our 
prior finding and elucidate complex I–independent mechanisms 
responsible for rotenone-induced dopamine neuron death.
Results
Complex I inhibition is insufficient to induce 
dopamine neuron death in culture and in 
the substantia nigra of Ndufs4
/ mice
We previously reported a lack of correlation between complex I 
inhibition and dopamine neuron death upon rotenone treatment 
or Ndufs4 deletion (Choi et al., 2008). Piericidin A is another 
well-characterized mitochondrial complex I inhibitor (Gutman 
et al., 1970; Murai et al., 2006). It is at least as potent as rote-
none in inhibiting complex I activity in primary mesencephalic 
Figure 1.  Complex I inhibition is not sufficient to induce dopamine neu-
ron death. Primary mesencephalic neurons were cultured from E14 mouse 
embryos and treated with rotenone or piericidin A after 5 DIV culture.   
(A and B) Dose response of the inhibition of complex I activities by rote-
none (A) or piericidin A (B). Complex I activity was measured in cells by 
oxygen consumption using the polarography method (C and D) Rotenone, 
but not piericidin A, selectively decreases the survival of TH
+ neurons over 
GABA
+ neurons. Values represent means. Error bars indicate SEM. n = 3; 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 2.  Ndufs4 inactivation does not cause dopamine neuron death. 
(A) Representative photomicrographs of TH immunostaining of SNpc from 
5-wk-old Ndufs4
+/+ and Ndufs4
/ mice. Bar, 500 µm. (B) Deletion of the 
Ndufs4 gene does not decrease the total number of TH
+ neurons in the 
SNpc of 5-wk-old mice (n = 5 per group). (C) Inactivation of the Ndufs4 
gene in culture does not induce dopamine neuron death. E14 mesen-
cephalic neurons were cultured from C57BL/6 or Ndufs4
lox/lox mouse 
embryos. AAV1 viruses expressing Cre-GFP were added to the culture 
on DIV 4 to delete the Ndufs4 gene in Ndufs4
lox/lox cells. The number of 
TH
+ neurons was quantified 5 d after viral infection. Data are means ± 
SEM. n = 3.875 Complex I inhibition in Parkinson’s disease model • Choi et al.
These data implicate microtubule depolymerization as an initial 
cell death signal upstream from cytochrome c release and acti-
vation of the mitochondrial apoptotic pathway.
Treatment of cell cultures with rotenone or colchicine   
increased intracellular dopamine (Fig. 4 A). Rotenone-induced 
dopamine accumulation was blocked by cotreatment with taxol, 
linking microtubule depolymerization to dopamine accumula-
tion. Rotenone-induced dopamine neuron death was attenuated 
by pretreatment with -methyl--tyrosine, an inhibitor of dopa-
mine  biosynthesis  (Fig.  4  B).  -Methyl--tyrosine  also  pre-
vented rotenone-induced dopamine accumulation (Fig. 4 C). 
These data suggest that rotenone and colchicine increased intra-
cellular dopamine to a toxic level, which contributes to their 
toxicity to dopamine neurons.
Consistent with dopamine accumulation, rotenone treat-
ment increased intracellular ROS content (Fig. 5 A). Impor-
tantly,  taxol  attenuated  rotenone  induction  of  ROS.  Finally, 
treatment with N-acetylcysteine, a free-radical scavenger and 
ROS inhibitor, protected TH
+ neurons from rotenone toxicity 
(Fig. 5 B). Collectively, these data suggest that the accumula-
tion of dopamine and ROS acts downstream from rotenone- 
induced microtubule depolymerization and underlies rotenone 
toxicity to dopamine neurons.
Role of NADH, microtubule dysfunction, 
dopamine, and ROS in rotenone toxicity 
and the hypersensitivity of Ndufs4
/ 
dopamine neurons
To investigate the mechanism underlying the enhanced sensitiv-
ity of Ndufs4
/ dopamine neurons to rotenone, we cultured 
Ndufs4
+/+ and Ndufs4
/ neurons from mesencephalons of indi-
vidual E14 embryos obtained by breeding Ndufs4
+/ mice. As 
with wild-type cultures, piericidin A did not induce dopamine 
cultures (Fig. S2). For both cultures, 50% of total TH
+ neurons 
were AAV1-Cre-GFP
+, indicating that Cre deletion of the Ndufs4 
gene in culture does not decrease dopamine neuron survival 
(Fig. 2 C). Together, these data further support our prior finding 
that complex I inhibition is insufficient to induce selective dopa-
mine neuron death.
Rotenone-induced dopamine neuron death 
may involve microtubule depolymerization, 
accumulation of dopamine, and reactive 
oxygen species (ROS)
If rotenone is toxic for cultured dopamine neurons lacking com-
plex I activity, what is the alternative mechanism for rotenone 
toxicity? It has been reported that rotenone induces microtubule 
depolymerization, which disrupts vesicular transport and causes 
dopamine accumulation and oxidative stress (Brinkley et al., 
1974; Marshall and Himes, 1978; Ren et al., 2005). To evaluate 
microtubule depolymerization, we performed immunostaining 
for -tubulin to visualize microtubules (Fig. 3 A) and Western 
blot  analysis  to  detect  free  (depolymerized)  versus  complex 
(polymerized) tubulin (Fig. 3 B). Interestingly, rotenone, but 
not piericidin A, caused microtubule depolymerization in pri-
mary mesencephalic cultures, correlating with their selective 
toxicity to dopamine neurons. In addition, the level of free tubu-
lin was increased 3–12 h after rotenone treatment (Fig. 3 C), 
whereas the detyrosinated, relatively “old” or stable form of tu-
bulin (Glu-tubulin; Ertürk et al., 2007) was decreased 9–12 h 
after rotenone treatment (Fig. 3 C). Inhibiting microtubule depoly-
merization by cotreatment with taxol, a microtubule-stabilizing 
agent, attenuated rotenone-induced TH
+ neuron death as well as 
cytochrome c release (Fig. 3, D and E). Furthermore, treatment 
with colchicine, a known microtubule-depolymerizing agent, in-
duced TH
+ neuron death to the same extent as rotenone (Fig. 3 D). 
Figure 3.  Rotenone-induced dopamine neuron death is mediated 
through microtubule depolymerization. E14 mouse mesencephalic 
neurons were treated on DIV 6 as indicated. (A) 5 nM rotenone, 
but not 10 nM piericidin A, induces microtubule fragmentation, 
which is indicative of microtubule depolymerization. Images are 
representative photomicrographs of immunostaining for -tubulin 9 h 
after treatment. Bar, 30 µm. (B) Western blot analysis reveals an 
increase in free (depolymerized) tubulin after a 9-h treatment with 
5 nM rotenone but not with 10 nM piericidin A. Complex (polymer-
ized) tubulin was used as a control. (C) A time course of 10 nM 
rotenone–induced microtubule depolymerization was analyzed by 
Western blotting. Anti–-tubulin antibody was used to detect free 
tubulin, whereas anti–Glu-tubulin antibody was used to detect the 
detyrosinated, relatively old or stable form of tubulin. (D) 10 nM 
taxol attenuates dopamine neuron death induced by 5 nM rote-
none for 24 h, whereas 5 µM colchicine for 24 h kills dopamine 
neurons. (E) Cotreatment with 10 nM taxol blocks cytochrome c 
release induced by 5 nM rotenone for 9 h. The relative intensity (RI) 
of protein bands on Western blots was quantified using ImageJ. 
Data are means ± SEM. n = 3; *, P < 0.05; **, P < 0.01; ***, 
P < 0.001.JCB • VOLUME 192 • NUMBER 5 • 2011   876
concentrations. Upon rotenone treatment, the normal vesicular 
dopamine transport and release may be blocked as a result of 
microtubule destabilization. Thus, the combination of Ndufs4 
deletion and microtubule dysfunction causes more dopamine 
accumulation and ROS production than microtubule dysfunc-
tion alone, resulting in the hypersensitivity of Ndufs4
/ dopa-
mine neurons to rotenone or colchicine.
To test this hypothesis, we measured NADH content in 
mesencephalic neurons cultured from Ndufs4
+/+ and Ndufs4
/ 
littermates  by  two-photon  microscopy  (Kuksa  et  al.,  2003).   
Indeed, there was a statistically significant increase in NADH 
levels in cultures from Ndufs4
/ mice (Fig. 7 A). Rotenone 
treatment increased intracellular dopamine content in TH
+ neu-
rons from Ndufs4
+/+ cultures, and the increase was much greater 
in TH
+ neurons prepared from Ndufs4
/ mice (Fig. 7 B). Co-
treatment with taxol significantly blocked rotenone induction of 
dopamine accumulation in both cultures (Fig. 7 C). Further-
more, -methyl--tyrosine improved the survival of TH
+ neu-
rons cultured from Ndufs4
/ mice to the same level as those 
from Ndufs4
+/+ mice.
Consistent with the dopamine increase, rotenone-induced 
ROS  increase  was  greater  in  TH
+  neurons  prepared  from 
Ndufs4
/ mice than in those from Ndufs4
+/+ mice (Fig. 8 A). 
Taxol attenuated rotenone induction of ROS to the same level 
in both cultures (Fig. 8 B). Finally, treatment with N-acetyl-
cysteine protected TH
+ neurons of both genotypes from rote-
none toxicity to a similar degree (Fig. 8 C). Collectively, 
neuron death in Ndufs4
/ cultures (Fig. 6 A). Furthermore,   
rotenone caused microtubule depolymerization (Fig. 6 B), and 
either rotenone or colchicine induced dopamine neuron death 
(Fig. 6, C and D) in Ndufs4
/ cultures lacking complex I activity. 
These data suggest that microtubule depolymerization may be 
responsible for toxicity independent of complex I inhibition.
Significantly, Ndufs4
/ dopamine neurons were even more 
sensitive to either rotenone or colchicine (Fig. 6, C and D). 
These data suggest that although complex I inhibition by it-
self is insufficient to kill dopamine neurons, it can potentiate 
dopamine neuron toxicity induced by microtubule dysfunction. 
What mechanisms underlie this hypersensitivity? Because rote-
none induced similar levels of microtubule depolymerization in 
both Ndufs4
+/+ and Ndufs4
/ cultures (Fig. 6 B), loss of com-
plex I activity must act outside of microtubule stability to make 
dopamine neurons more vulnerable to microtubule dysfunction. 
We hypothesize that loss of complex I activity elevates the com-
plex I substrate NADH, which stimulates endogenous dopamine 
biosynthesis by enhancing the recycling of tetrahydrobiopterin, 
a cofactor for TH (Vrecko et al., 1993, 1997). However, under 
resting conditions, the increase in dopamine may be modest and 
insufficient to cause oxidative stress because vesicular transport 
and release are sufficient to maintain low cytoplasmic dopamine 
Figure 4.  Dopamine accumulation underlies rotenone toxicity. (A) 10 nM 
rotenone for 8 h and 5 µM colchicine for 8 h increase total intracellular 
dopamine content, whereas cotreatment with 10 nM taxol blocks rotenone-
induced dopamine accumulation. (B) Rotenone-induced dopamine neuron 
death  is  attenuated  by  pretreatment  with  -methyl--tyrosine  (AMPT),  a 
dopamine synthesis inhibitor. 0.2-mM -methyl--tyrosine was added 2 h 
before and maintained during 5 nM rotenone treatment for 24 h. (C) 0.2 mM 
-methyl--tyrosine prevents 10 nM rotenone–induced dopamine accumu-
lation. Data are means ± SEM. n = 3; *, P < 0.05; **, P < 0.01.
Figure  5.  Oxidative  stress  contributes  to  rotenone-induced  dopamine 
neuron death. (A) 5 nM rotenone for 12 h increases ROS production in TH
+ 
neurons, which is prevented by cotreatment with 10 nM taxol. (B) Cotreat-
ment with 0.5 mM N-acetylcysteine (NAC), an antioxidant, reduces 24-h 
5-nM rotenone–induced TH
+ neuron death. Data are means ± SEM. n = 3; 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.877 Complex I inhibition in Parkinson’s disease model • Choi et al.
Discussion
Although mitochondrial complex I dysfunction has long been 
implicated in dopamine neuron death and the pathogenesis of 
Parkinson’s disease, a causal relationship has not been firmly 
established. Dopamine neurons cultured for 1 wk from the mes-
encephalon of E14 Ndufs4
/ mouse embryos have no signifi-
cant complex I activity, yet they appear normal without apparent 
defects in survival (Choi et al., 2008). The objective of this 
study was to provide additional evidence to support our prior 
finding that complex I inhibition is not sufficient to induce dopa-
mine neuron death and to elucidate alternative mechanisms 
underlying rotenone-induced, complex I–independent dopa-
mine neuron toxicity. We demonstrate in this study that pieri-
cidin A, another potent complex I inhibitor, does not induce 
selective dopamine neuron death, that in-culture deletion of the 
Ndufs4 gene does not kill dopamine neurons, and that Ndufs4 
deletion does not change the number of TH
+ neurons in the 
SNpc in vivo in 5-wk-old mice. These data support our prior 
finding that complex I inhibition is not a direct cause of dopa-
mine neuron death.
What is the mechanism by which rotenone selectively induces 
the death of dopamine neurons lacking complex I activity? We   
illustrate that rotenone causes microtubule depolymerization and 
the accumulation of dopamine and ROS in mesencephalic cultures. 
these  data  suggest  that  the  increase  in  basal  NADH  and   
the greater accumulation of dopamine and ROS after rote-
none treatment in Ndufs4
/ cultures may explain why dopa-
mine neurons lacking complex I activity are more sensitive 
to rotenone.
Rotenone toxicity to dopamine neurons 
may involve VMAT2 inhibition and the 
accumulation of cytoplasmic dopamine
Cytosolic, but not vesicular, dopamine is subject to oxidation, 
which promotes oxidative stress (Hastings et al., 1996). Thus, 
we determined whether rotenone increases cytosolic dopamine. 
Cultures treated with reserpine, an inhibitor of VMAT (vesicu-
lar monoamine transporter), were used as a positive control. As 
expected,  reserpine  increased  cytosolic  dopamine  while  de-
creasing vesicular dopamine (Fig. 9, A and B). Rotenone did 
not change the level of vesicular dopamine but significantly in-
creased total (Fig. 4 A) as well as cytosolic (Fig. 9 B) dopa-
mine. To further test this hypothesis, we enhanced VMAT2 
function by transducing cultures with an adenovirus express-
ing VMAT2 (Mosharov et al., 2009); this treatment inhibited 
rotenone-induced TH
+ neuron death (Fig. 9 C). These data sup-
port the hypothesis that rotenone disrupts VMAT2 function and 
thereby  enhances  accumulation  of  cytoplasmic  dopamine, 
which is toxic.
Figure 6.  Ndufs4-deficient dopamine neurons are more sensitive to rote-
none and colchicine. Mesencephalic neurons were cultured from individual 
E14 Ndufs4
+/+ and Ndufs4
/ embryos. (A) 10 nM piericidin A for 24 h 
does not cause dopamine neuron death in Ndufs4
+/+ or Ndufs4
/ cul-
tures. (B) 5 nM rotenone for 9 h increases free (depolymerized) tubulin 
to the same extent in Ndufs4
/ cultures as it does in Ndufs4
+/+ cultures. 
The relative intensity (RI) of tubulin protein bands on Western blots was 
quantified using ImageJ. (C) 5 nM rotenone for 24 h kills more Ndufs4
/ 
dopamine neurons than Ndufs4
+/+ ones. (D) 5 µM colchicine for 24 h ex-
erts more toxicity in dopamine neurons prepared from Ndufs4
/ than 
from Ndufs4
+/+ embryos. Data are means ± SEM. n = 3; *, P < 0.05; 
**, P < 0.01.
Figure 7.  NADH and dopamine accumulation underlie hypersensitivity 
of Ndufs4
/ neurons to rotenone. Mesencephalic neurons were cultured 
from individual E14 Ndufs4
+/+ and Ndufs4
/ embryos. (A) Deletion of   
the Ndufs4 gene increases basal intracellular NADH content. (B) 8-h 10-nM 
rotenone–induced  intracellular  dopamine  accumulation  is  significantly 
higher in Ndufs4
/ cultures than in Ndufs4
+/+ cultures. (C) 10 nM taxol 
inhibits  8-h  10-nM  rotenone–induced  dopamine  accumulation  in  both 
Ndufs4
+/+ and Ndufs4
/ cultures. (D) Pretreatment with 0.2-mM -methyl-
-tyrosine (AMPT) protects dopamine neurons cultured from both Ndufs4
+/+ 
and Ndufs4
/ embryos against 5-nM rotenone toxicity for 24 h. Data are 
means ± SEM. n = 3–4; *, P < 0.05; **, P < 0.01.JCB • VOLUME 192 • NUMBER 5 • 2011   878
Interestingly, several Parkinson’s disease–related genes, 
including parkin and -synuclein, have been implicated in the reg-
ulation of microtubule dynamics. Overexpression of -synuclein 
impairs microtubule-dependent trafficking (Lee et al., 2006). Par-
kin, a protein–ubiquitin E3 ligase, ubiquitinates - and -tubulin 
and accelerates their degradation (Ren et al., 2003). Parkin-
son’s disease–linked mutations abolish these effects of par-
kin, which may result in the accumulation of misfolded or 
damaged  tubulin.  Parkin  also  protects  dopamine  neurons 
against colchicine (Ren et al., 2009). Transgenic mice ex-
pressing a mutant microtubule-associated protein tau found in 
frontotemporal dementia develop early onset tremor, bradyki-
nesia, abnormal gait, and postural instability, which are re-
versible by l-3,4-dihydroxyphenylalanine (Ittner et al., 2008). 
Our  data  illustrate  that  treatment  with  the  microtubule- 
depolymerizing agent colchicine is sufficient to cause dopa-
mine neuron death in primary cultures. Together with our data 
on the differential effects of rotenone and piericidin A on micro-
tubule  function  and  dopamine  neuron  death,  these  results 
Inhibition of microtubule depolymerization by cotreatment with 
taxol almost completely inhibited these processes and blocked   
rotenone-induced loss of TH
+ neurons cultured from both 
Ndufs4
+/+ and Ndufs4
/ littermates. Furthermore, piericidin A 
did not cause microtubule depolymerization. Treatment with col-
chicine, a microtubule-depolymerizing agent, induced dopamine 
accumulation and dopamine neuron death. These data implicate 
microtubule depolymerization and the accumulation of dopamine 
and ROS as alternative mechanisms underlying rotenone-induced, 
complex I–independent dopamine neuron death. Our data are 
consistent with previous work from other laboratories (Ren et al., 
2005; Feng, 2006; Ogburn and Figueiredo-Pereira, 2006).
We discovered that loss of complex I activity elevates 
baseline NADH levels. The NADH increase and microtubule 
destabilization associated with rotenone treatment cause greater 
dopamine and ROS accumulation in Ndufs4
/ dopamine neu-
rons than in Ndufs4
+/+ dopamine neurons. This may explain 
why rotenone-induced TH
+ neuron loss is greater in Ndufs4
/ 
neurons  compared  with  Ndufs4
+/+  neurons.  This  hypothesis 
agrees with the report that overproduction of dopamine is suffi-
cient to induce dopamine neuron death (Park et al., 2007b).
Figure 8.  Role of ROS production in the hypersensitivity of Ndufs4
/ 
neurons to rotenone. Mesencephalic neurons were cultured from individual 
E14 Ndufs4
+/+ and Ndufs4
/ embryos. (A) 5 nM rotenone for 8 h in-
creases intracellular ROS significantly more in dopamine neurons cultured 
from Ndufs4
/ embryos than those from Ndufs4
+/+ embryos. (B) 10 nM 
taxol prevents 8-h 5-nM rotenone–induced ROS production in Ndufs4
+/+ 
and Ndufs4
/ cultures. (C) 0.5 mM N-acetylcysteine (NAC) protects do-
pamine neurons cultured from both Ndufs4
+/+ and Ndufs4
/ embryos 
against 5-nM rotenone toxicity for 24 h. Data are means ± SEM. n = 3–4; 
*, P < 0.05; **, P < 0.01.
Figure 9.  Rotenone increases dopamine accumulation in the cytosol, sug-
gesting that it may inhibit VMAT2 activity. (A and B) E14 mouse mesen-
cephalic cultures were treated with 10 nM rotenone for 8 h or 0.2 µM 
reserpine  for  8  h.  Dopamine  concentration  was  measured  from  both 
synaptosome (vesicular; A) and cytosolic fractions (B). (C) Ectopic expres-
sion of VMAT2 protects dopamine neurons against rotenone. E14 mouse 
mesencephalic cultures were infected with VMAT2-expressing adenovirus   
or control GFP virus 2 d before 5-nM rotenone treatment for 24 h. The   
total number of TH
+ neurons was counted. Data are means ± SEM. n = 3; 
*, P < 0.05.879 Complex I inhibition in Parkinson’s disease model • Choi et al.
as a result of Ndufs4 gene inactivation coupled with micro-
tubule dysfunction exacerbated the accumulation of dopamine 
and ROS. These data suggest that although complex I inhibition 
is insufficient to kill dopamine neurons, it can potentiate dopa-
mine neuron death caused by microtubule dysfunction. Our re-
sults suggest that the combination of inhibiting complex I and 
disrupting microtubule dynamics, either by genetic mutations 
or exposure to toxicants, may present an increased risk for 
Parkinson’s disease.
Materials and methods
Generation of Ndufs4-null (Ndufs4
/) mice or embryos
The generation and characterization of Ndufs4
/ mice or embryos have 
been previously described (Kruse et al., 2008). The Ndufs4 heterozygotes 
(Ndufs4
+/) were bred to generate littermates of Ndufs4
+/+, Ndufs4
+/, 
and Ndufs4
/ mice or embryos. PCR genotyping results were matched to 
each embryo at the end of the experiment. For the in vitro knockout experi-
ments, mesencephalic primary neurons were cultured from E14 embryos 
taken from Ndufs4
lox/lox mice (Kruse et al., 2008); embryos from wild-type 
C57BL/6 mice were used as controls.
Primary mesencephalic neuron cultures and drug treatments
Primary cultured dopamine neurons were prepared from E14 mouse em-
bryos as previously described (Choi et al., 2008), either as single embryo 
cultures (for Ndufs4
+/+ and Ndufs4
/ cultures) or as pooled cultures from 
one to two pregnant C57BL/6 or Ndufs4
lox/lox mice. The plug day was de-
fined as E0.5. Drugs were obtained from Sigma-Aldrich unless otherwise 
specified. Drug treatments were performed in defined serum-free N2 me-
dium (Invitrogen). Half of the media was replaced with N2 medium on the 
day before drug treatment and then again at the time of drug treatment. 
Cells  treated  with  vehicle  alone  were  used  as  controls.  Cultures  were 
treated on day in vitro (DIV) 5–6 with various drugs or on DIV 4 with AAV1-
Cre-GFP. VMAT2-expressing adenovirus or control GFP virus (gift from   
E.V. Mosharov and D. Sulzer, Columbia University, New York, NY) was   
infected 2 d before rotenone treatment.
Polarography
Monitoring of mitochondrial oxygen consumption was performed in cells 
(not purified mitochondria) as previously described (Choi et al., 2008).   
In brief, healthy intact E14 cultured neurons grown on coverslips were placed 
in respiration buffer, pH 7.3, consisting of 225 mM mannitol, 75 mM su-
crose, 10 mM KCl, 5 mM Hepes, 5 mM K2HPO4, and 1 mg/ml of freshly 
added defatted BSA in an oxygen-monitoring apparatus (5300A system; 
YSI Life Sciences) at 37°C. Mitochondrial complex I activity was measured 
by monitoring a 1.25-µM rotenone-sensitive oxygen consumption rate in 
the presence of complex I–specific substrates (10 mM pyruvate/2 mM   
malate/1 mM ADP). The amount of oxygen consumed was calculated, as-
suming the initial oxygen concentration in the buffer was 0.223 µmol O2/ml.
Immunocytochemistry and quantification of TH
+ or -aminobutyric acid 
(GABA)–releasing neurons
These procedures were performed as previously described (Choi et al., 
2008). In brief, cells were fixed with 4% paraformaldehyde/4% sucrose at 
room temperature for 30 min and blocked for 1 h in blocking buffer (PBS 
containing 5% BSA, 5% normal goat serum, and 0.1% Triton X-100). Cells 
were then incubated with primary antibodies in blocking buffer at 4°C 
overnight.  Primary  antibodies  included  mouse  monoclonal  antibody 
against TH (TH, 1:500; Sigma-Aldrich), rabbit polyclonal antibody against 
TH  (1:50,000;  Pel-Freez),  rabbit  polyclonal  antibody  against  GABA 
(1:5,000; Sigma-Aldrich), and -tubulin (1:2,000; Sigma-Aldrich). After 
three washes with PBS, cells were incubated at room temperature for 1 h 
with appropriate secondary antibodies. Secondary antibodies were Alexa 
Fluor 488 (or 568) goat anti–rabbit IgG and Alexa Fluor 568 (or 488) 
goat anti–mouse IgG (1:200; Invitrogen). Images for -tubulin staining 
(Fig. 3 A) were taken at room temperature using an imaging system (Mari-
anas; Intelligent Imaging Innovations, Inc.), which incorporates a fluores-
cence  microscope  (Axiovert  200M;  Carl  Zeiss,  Inc.)  with  a  motorized 
stage, a shuttered 175-W xenon lamp, a digital camera (CoolSNAP HQ; 
Roper Industries), and a 40× objective lens (Axiovert). Cells that were   
immunostained positive for TH or GABA antibodies and had neurites twice 
the length of the soma were scored as TH
+ or GABA
+ cells. All TH
+ cells on 
suggest that damage and malfunction of microtubules may   
underlie dopamine neuron death in Parkinson’s disease. Micro-
tubule dysfunction could interfere with the axonal transport of 
essential molecules from the cell body to the axon terminals as 
well as removing molecules destined for degradation away from 
the axon. Thus, the microtubule dysfunction mechanism could 
explain, at least in part, the “dying back” phenomenon of dopa-
mine neurons in Parkinson’s disease, a process in which neurites 
degenerate before cell death.
Microtubule function is required for vesicular transport 
and  release.  Our  data  showed  that  rotenone-induced  micro-
tubule depolymerization led to an increase in total dopamine. 
However, only cytosolic, but not vesicular, dopamine is subject 
to oxidation, which elevates ROS and can cause neuron death 
(Hastings et al., 1996). Indeed, rotenone-induced increase in   
total dopamine was coupled with an increase in cytosolic dopa-
mine. Because VMAT2 is the primary transporter that packages 
dopamine into presynaptic vesicles in dopamine neurons of the 
SNpc, our data implicate rotenone inhibition of VMAT2 func-
tion in primary dopamine neurons. The combined effect of   
microtubule depolymerization and VMAT2 inhibition increases 
total and cytosolic dopamine after rotenone treatment. Consis-
tent with our findings, transgenic mice with low VMAT2 activ-
ity  have  reduced  vesicular  dopamine  content  and  develop 
progressive  dopamine  neuron  degeneration  (Caudle  et  al., 
2007). Rotenone inhibits and redistributes VMAT2 and in-
creases  cytosolic  dopamine  in  SHSY5Y  cells  (Watabe  and   
Nakaki, 2007, 2008).
Our results do not seem to agree with the findings derived 
from ectopic expression of Ndi1, a yeast single-subunit NADH 
dehydrogenase gene. Ectopic expression of Ndi1 rescues dopa-
mine neurons from rotenone toxicity in vitro and in vivo, lead-
ing to the conclusion that complex I inhibition is obligatory for 
dopamine neuron death in the rotenone model of Parkinson’s 
disease (Sherer et al., 2003a, 2007; Marella et al., 2008). How-
ever, alternative explanations exist for these results. For exam-
ple, per our hypothesis, ectopic overexpression of Ndi1 could 
reduce NADH concentration and subsequent dopamine bio-
synthesis in dopamine neurons, making them less vulnerable   
to rotenone. Furthermore, because intracellular ATP and other 
NTPs can bind to cytochrome c, inhibit apoptosome formation, 
and are critical prosurvival factors (Chandra et al., 2006), it is con-
ceivable that overexpressing Ndi1 may increase ATP production 
and promote the survival of dopamine cells against a host of cell 
death signals that are unrelated to complex I inhibition, such as 
oxidative  stress.  Indeed,  overexpression  of  Ndi1  completely 
blocked cell death induced by several pesticides that are not 
known to be complex I inhibitors, including pyridaben, fen-
pyroximate, fenazaquin, and tebufenpyrad (Sherer et al., 2007). 
Ndi1 expression also prevented cell death induced by paraquat 
(Park et al., 2007a), whose cytotoxicity is largely caused by oxi-
dative stress but is independent of complex I inhibition (Day   
et al., 1999; Jones and Vale, 2000; Dauer and Przedborski, 
2003; Bonneh-Barkay et al., 2005; McCormack et al., 2005; 
Richardson et al., 2005).
Intriguingly, Ndufs4
/ dopamine neurons were even more 
sensitive to rotenone or colchicine. The loss of complex I activity JCB • VOLUME 192 • NUMBER 5 • 2011   880
and washed with and then incubated in PBS at 37°C for another 15 min. 
The images of eight fields from each well were captured with an inverted 
fluorescence microscope (E400) equipped with a digital camera (MagnaFire) 
and a temperature-controlled stage at 37°C. Cells were then fixed with 4% 
paraformaldehyde and processed for anti-TH immunostaining. After stain-
ing, images from the same eight fields were captured and compared. The 
staining intensity of the CM-DCFDA dye (ROS) in the TH
+ neuron popula-
tion  was  quantified  using  the  ImageJ  program  (National  Institutes  of 
Health). All TH
+ neurons in captured images were scored, and the mean 
ROS level per TH
+ neuron was calculated.
Measurement of intracellular NADH content
Two-photon excitation microscopy was used to measure the intracellular 
NADH content as previously described (Kuksa et al., 2003). Cells were 
grown for 5 d on 25-mm glass coverslips (Corning). The coverslips were 
mounted on a temperature-controlled microscopic stage (Heating Insert P; 
Carl Zeiss, Inc.) installed on the microscope to maintain the medium tem-
perature at 37°C. The objective lens was preheated up to 37°C by an air 
stream incubator (ASI 400; Nevtek). NADH autofluorescence (435–485 nm) 
from the sample was collected through the objective lens, separated 
from the excitation light by a dichroic mirror, filtered by BG39 to remove 
scattered UV light, and directed to a photomultiplier tube detector (LSM 
510; Carl Zeiss, Inc.). NADH intensity was imaged using a 20× 1.3 NA 
Plan Neofluar objective lens (Carl Zeiss, Inc.) and 76-MHz, 100-fs pulses 
of a 730-nm light from a mode-locked Ti:Sapphire laser (Mira; Coherent, 
Inc.). Images were analyzed with the AIM Image Examiner program (Carl 
Zeiss, Inc.) and the ImageJ program.
Dopamine measurement
E14 mesencephalic primary neurons (3–4 × 10
5 cells) were plated on 
each well of the 24-well plates. Duplicate sets of cells were treated equally 
with drugs or vehicle control. One set was fixed and immunostained for TH 
to quantify the total number of TH
+ neurons. The other set (2–4 wells for 
each treatment) of cells was frozen on dry ice, stored at 80°C, and sent 
to the Neurochemistry Core Laboratory at Vanderbilt University’s Center 
for Molecular Neuroscience Research to analyze for dopamine content, 
which was done without prior knowledge of genotypes or drug treatments. 
In brief, cells were homogenized with 0.1 M trichloroacetic acid contain-
ing 10 mM sodium acetate/0.1 mM EDTA/1 mM isoproterenol (internal 
standard)/10.5% methanol, pH 3.8, and centrifuged at 10,000 g for   
20 min. Total dopamine content in the supernatant was quantified by HPLC 
coupled with electrochemical detection (0.7 V). The HPLC system (Antec 
Leyden) consisted of a 515 HPLC pump, a 717 plus autosampler, an elec-
trochemical detector (Decade II; Antec Leyden), and an HPLC column 
(150 × 4.6 mm; Nucleosil C18; Phenomenex). The homogenization buffer 
was used as the mobile phase (0.7 ml/min), and 20 µl of the sample was 
injected onto an HPLC column (3.9 × 300 mm; Nova-Pak C18; Waters). 
Dopamine content was normalized to the number of TH
+ neurons in each 
treatment group. For the cytosolic or vesicular dopamine measurement, 
synaptosome and cytosol fractions were prepared using a synaptic vesicle 
preparation kit (SV0100; Sigma-Aldrich) and sent to the Neurochemistry 
Core Laboratory for dopamine measurement.
Statistical analysis
Data were from at least three independent experiments, each with at least 
duplicate or triplicate determinations. Statistical analyses of data were per-
formed using two-way analysis of variance and posthoc Student’s t test.
Online supplemental material
Fig.  S1  shows  the  quantification  of  TH  immunostaining  of  SNpc  from   
6–7-wk-old Ndufs4
+/+ and Ndufs4
/ mouse brains. Fig. S2 shows that 
AAV-Cre  knocks  down  Ndufs4  protein  expression  in  Ndufs4
lox/lox  cultures   
prepared from E14 mesencephalon. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201009132/DC1.
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a 9-mm diameter ACLAR embedding film were scored. The number of TH
+ 
neurons in one ACLAR embedding film was 100–200 in control cultures 
(vehicle control). Cells that were immunostained positive for the GABA   
antibody were counted from five representative fields from each ACLAR 
embedding film and scored as the GABAergic population.
Immunohistochemistry and quantification of TH
+ neurons in the SNpc
5-wk-old Ndufs4
+/+ and Ndufs4
/ littermate mice were perfused with hepa-
rinized saline followed by 4% paraformaldehyde as previously described 
(Choi et al., 2010). Harvested brains were postfixed in 4% paraformalde-
hyde overnight and then cryoprotected in PBS with 30% sucrose for ≥2 d. 
Fixed brains were cut into 40-µm sections and collected in cryoprotectant. 
Sections were incubated with an antibody against TH (1:5,000; Pel-Freez) 
in PBS containing 0.1% Triton X-100, 5% BSA, and 5% goat serum. Sec-
tions were washed and incubated with biotin-labeled secondary antibody 
and avidin-biotin solution using the VECTASTAIN Elite kit (Vector Laborato-
ries) for 1 h each at room temperature. Sections were developed in DAB for 
2–5 min, rinsed several times in tap water, and mounted. Images for TH 
staining (Fig. 2 A) were collected at room temperature with an inverted   
fluorescence microscope (E400; Nikon) using a 4× objective lens (Nikon) 
equipped with a digital microscope camera (MagnaFire; Optronics, Inc.). 
MagnaFire software was used for system control and image processing. 
TH
+ neurons were counted stereologically as previously described (Mandir 
et al., 1999). In brief, low magnification (2.5×) images were taken under a 
microscope (Axiovert 200M) equipped with motorized stage in three axes. 
The boundaries of SNpc were outlined using the set of anatomical land-
marks according to the mouse brain atlas (Hof et al., 2000). The number of 
TH
+ neurons was counted at high power (65×) at automatically selected 
random fields of the SNpc, and the number of total TH
+ neurons on each 
slide was calculated following optical dissector rules using a cell counter 
(StereoInvestigator System; MicroBrightField, Inc.). We began cell counting 
at the first slide of the SNpc section when TH
+ neurons were visible and then 
on every fourth slide through the entire SNpc. The estimate of the total num-
ber of TH
+ neurons in each brain was calculated using the optical dissector 
method (Mandir et al., 1999). Five brains from each genotype (Ndufs4
+/+ 
and Ndufs4
/) were analyzed for stereological cell counting and pre-
sented as the total number of TH
+ neurons in the SNpc of each brain.
Immunoblot analysis
Protein lysates were prepared from cells and analyzed by SDS-PAGE gel 
electrophoresis and Western blotting as previously described (Choi et al., 
2010). Mouse monoclonal anti–cytochrome c antibody (1:3,000) was pur-
chased from Santa Cruz Biotechnology, Inc. Antibodies against -tubulin 
and Glu-tubulin were purchased from Sigma-Aldrich.
Preparation of the cytosolic and mitochondrial fraction for cytochrome c 
release assay
Cytochrome c release was assayed as previously described (Gross et al., 
1998; Choi et al., 2004). In brief, cells were washed with PBS, resus-
pended in isotonic buffer A (250 mM sucrose, 1 mM EGTA, 10 mM Hepes, 
pH 8.0, 1 mM DTT, and protease inhibitors), and homogenized using an 
A-type Dounce homogenizer (Kontes) 40 times. Nuclei and unbroken cells 
were removed by centrifugation at 120 g for 5 min as the pellet. The super-
natant was centrifuged again at 10,000 g for 10 min to collect the heavy 
membrane pellet (mitochondria), whereas the supernatant was designated 
the cytosolic fraction (cytosol). The heavy membrane pellet was lysed by 
vortexing and resuspending it in resuspension buffer (10 mM Hepes, 5 mM 
MgCl2, 42 mM KCl, and 1% Triton X-100) for 5 min on ice.
Preparation of free and complex tubulin
Free or polymerized tubulin was extracted from cultured cells as previously de-
scribed (Jiang et al., 2006). In brief, midbrain neuronal cultures maintained in 
24-well plates were washed twice at 37°C with 1 ml of buffer A containing 
0.1 M MES, pH 6.75, 1 mM MgSO4, 2 mM EGTA, 0.1 mM EDTA, and 4 M 
glycerol. The cultures were then incubated at 37°C for 5 min in 300 µl of free 
tubulin extraction buffer (buffer A plus 0.1% [vol/vol] Triton X-100 and prote-
ase inhibitors). The extracts were centrifuged at 37°C for 2 min at 16,000 g. 
The supernatant fractions contained free cytosolic tubulin. The pellet fraction 
and lysed cells remaining in the culture dish retained polymerized tubulin in 
microtubules and were dissolved in 600 µl of 25 mM Tris, pH 6.8, plus 0.5% 
SDS. Equal amounts of total protein from free or polymerized tubulin fractions 
were analyzed by Western blotting with an anti–-tubulin antibody.
ROS labeling and quantification
Cells were incubated at 37°C for 15 min with 5 µM CM-DCFDA (5-(and-6)-
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